Myconostica
Irish clinical diagnostics company Trinity Biotech has acquired the blood bank screening and certain molecular assets of UK-based personalized medicine and clinical diagnostics firm Lab21, the companies said today.
BD Diagnostics, a segment of Becton Dickinson, and Lab 21 will develop the real-time PCR-based test as an in vitro diagnostic product.
The acquisition gives Lab21 access to its first set of nucleic acid-based assays, including a growing menu of RT-PCR and microarray-based tests.
Apr 7, 2011
Dec 9, 2010
Sep 28, 2010
Sep 16, 2010
Sep 9, 2010
Aug 12, 2010
Jan 21, 2010
Jan 13, 2010